80 Biggest Movers From Yesterday

Gainers

• Taubman Centers, Inc. TCO shares jumped 53.2% to close at $53.12 on Monday. Simon Property Group, Inc. SPG said Monday it plans to purchase an 80% ownership interest in Taubman Centers-owned Taubman Realty Group for $52.50 per share in cash.
• vTv Therapeutics Inc. VTVT shares climbed 52.3% to close at $3.20 on Monday after the company reported the results from part 2 of the Phase 2 Simplici-T1 study of TTP399 achieved the primary objective of a statistically significant reduction in HbA1c.
• Youdao, Inc. DAO shares rose 39.5% to close at $29.50.
• Kezar Life Sciences, Inc. KZR shares gained 34.6% to close at $5.02.
• Co-Diagnostics, Inc. CODX climbed 32% to close at $3.96 after the company announced orders for its new coronavirus test.
• Edgewell Personal Care Company EPC rose 27.5% to close at $38.87 after the company reported better-than-expected Q1 results and announced plans to call off its acquisition of Harry’s Inc. Consumer Edge Research upgraded Edgewell Personal Care from Equal-Weight to Overweight.
• Mereo BioPharma Group plc MREO shares jumped 27.4% to close at $2.00. Mereo BioPharma reported a $5 million convertible equity financing with Novartis and disclosed a securities purchase deal with Aspire Capital Fund for up to $28 million.
• Onconova Therapeutics, Inc. ONTX gained 22.5% to close at $0.60 after climbing 12.28% on Friday.
• Stoke Therapeutics, Inc. STOK shares climbed 21.8% to close at $34.15.
• China Online Education Group COE shares rose 21.1% to close at $21.50.
• China Distance Education Holdings Limited DL rose 20.6% to close at $10.60.
• eGain Corporation EGAN surged 20.1% to close at $10.03.
• Aquestive Therapeutics, Inc. AQST rose 17.9% to close at $4.67 after the company reported FDA acceptance of New Drug Application for libervant buccal film.
• Adverum Biotechnologies, Inc. ADVM shares gained 17.7% to close at $12.05 after the company reported the interim data from the Cohorts 1 and 2 of OPTIC Phase 1 trial of ADVM-022 intravitreal gene therapy showed robust efficacy with evidence of a dose-response. Cantor Fitzgerald upgraded Adverum Biotechnologies from Neutral to Overweight and raised the price target from $8 to $21.
• NanoViricides, Inc. NNVC shares rose 17.4% to close at $8.16.
• Atomera Incorporated ATOM shares jumped 17.3% to close at $4.89.
• Bellicum Pharmaceuticals, Inc. BLCM rose 17% to close at $11.35.
• Maui Land & Pineapple Company, Inc. MLP gained 16.8% to close at $12.35.
• Abeona Therapeutics Inc. ABEO gained 16.7% to close at $2.93.
• Lithium Americas Corp. LAC climbed 16.7% to close at $4.83.
• Invacare Corporation IVC climbed 15.9% to close at $8.77 following Q4 results.
• Slack Technologies, Inc. WORK rose 15.4% to close at $26.54.
• ACM Research, Inc. ACMR gained 15.4% to close at $41.59.
• LAIX Inc. LAIX shares climbed 15.1% to close at $5.25.
• Pyxus International, Inc. PYX gained 15% to close at $7.21. Pyxus reported Q3 results after the closing bell.
• Second Sight Medical Products, Inc. EYES rose 15% to close at $5.99.
• Mersana Therapeutics, Inc. MRSN surged 14.9% to close at $7.57.
• Photronics, Inc. PLAB climbed 14.7% to close at $14.76.
• HC2 Holdings, Inc. HCHC rose 14% to close at $3.99 after the company disclosed that it is in advanced discussions to sell Continental Insurance.
• ContraFect Corporation CFRX rose 13.8% to close at $7.74.
• Predictive Oncology Inc. POAI gained 13.3% to close at $2.73.
• Cue Biopharma, Inc. CUE climbed 13.3% to close at $18.96.
• Allied Healthcare Products, Inc. AHPI rose 12.9% to close at $2.54.
• Planet Green Holdings Corp. PLAG shares rose 11.9% to close at $2.26 after the company entered into share purchase agreement with two investors. The company will sell 1.35 million shares for $2.60 per share.
• Novavax, Inc. NVAX shares gained 11.3% to close at $7.02.
• The Macerich Company MAC gained 11.3% to close at $26.00 after declining 6.26% on Friday.
• Barnes & Noble Education, Inc. BNED gained 10% to close at $3.73.
• Information Services Group, Inc. III climbed 9.7% to close at $3.27.
• Mercury General Corporation MCY gained 9.7% to close at $53.70 following Q4 results.
• Osmotica Pharmaceuticals plc OSMT rose 9.6% to close at $5.59.
• America's Car-Mart, Inc. CRMT shares rose 9.6% to close at $117.00. America's Car-Mart will replace Care.com in the S&P SmallCap 600 on Thursday, February 13.
• Rockwell Medical, Inc. RMTI shares jumped 9.6% to close at $2.40.
• AVROBIO, Inc. AVRO gained 9.6% to close at $26.21.
• Inovio Pharmaceuticals, Inc. INO shares climbed 9.1% to close at $3.48 after the company received authorization from the U.S. FDA to begin Phase 1/2 clinical trial for INO-3107 to treat recurrent respiratory papillomatosis.
• The Pennant Group, Inc. PNTG gained 9.1% to close at $30.50.
• Gulf Resources, Inc. GURE rose 9% to close at $4.23.
• ZIOPHARM Oncology, Inc. ZIOP shares climbed 7.8% to close at $3.30.

Check out these big penny stock gainers and losers

Losers

• Valeritas Holdings, Inc. VLRX shares dipped 43.1% to close at $0.3625 on Monday after the company announced an agreement for Zealand Pharma to acquire business and retain employees.
• Can-Fite BioPharma Ltd. CANF shares tumbled 43.1% to close at $1.20. Can-Fite BioPharma priced its 3.33 million unit offering at $1.50 per unit.
• Technical Communications Corporation TCCO dropped 33.3% to close at $3.00.
• Myomo, Inc. MYO fell 25.7% to close at $11.65.
• Benitec Biopharma Limited BNTC shares declined 25.3% to close at $5.56 after jumping 40.64% on Friday.
• Acasti Pharma Inc. ACST shares fell 24.6% to close at $0.5707 after the company announced an investigation into its Phase 3 trials of CaPre is underway following 'inconsistent findings' that may have negatively impacted results in its TRILOGY 1 trial.
• Alector, Inc. ALEC dropped 17.1% to close at $29.26.
• Artelo Biosciences, Inc. ARTL fell 15.4% to close at $1.71
• Collegium Pharmaceutical, Inc. COLL dropped 15.1% to close at $21.62 after reporting a proposed convertible senior notes offering.
• CNX Resources Corporation CNX fell 14.2% to close at $6.36. CNX Resources reports a 8% year-over-year rise in total proved reserves as of Dec. 31, 2019.
• ION Geophysical Corporation IO fell 13.9% to close at $3.65.
• Tupperware Brands Corporation TUP shares declined 13.7% to close at $5.62.
• Yield10 Bioscience, Inc. YTEN fell 13% to close at $7.55 after declining 17.33% on Friday.
• Contura Energy, Inc. CTRA shares fell 11.5% to close at $5.67. Contura reported Q4 coal sales of $497 million.
• Ceragon Networks Ltd. CRNT dropped 11.5% to close at $1.84 after reporting Q4 results.
• Vivint Smart Home, Inc. VVNT dipped 11% to close at $12.60.
• Borr Drilling Limited BORR fell 10.9% to close at $4.19.
• Liquidia Technologies, Inc. LQDA shares fell 10.8% to close at $5.39.
• Intelsat SA I dropped 10.7% to close at $3.35 after Raymond James downgraded the company's stock from Outperform to Market Perform.
• Akers Biosciences, Inc. AKER dipped 10.7% to close at $3.16.
• Motorcar Parts of America, Inc. MPAA tumbled 10.5% to close at $19.06 after the company reported downbeat Q3 results.
• Whiting Petroleum Corporation WLL dropped 10.5% to close at $3.67.
• Phio Pharmaceuticals Corp. PHIO fell 10.5% to close at $6.67. Phio Pharmaceuticals announced compliance with Nasdaq listing requirements.
• The Manitowoc Company, Inc. MTW fell 10.2% to close at $12.63.
• Everspin Technologies, Inc. MRAM shares declined 10.1% to close at $4.02.
• My Size, Inc. MYSZ fell 9.9% to close at $2.37 after rising 9.58% on Friday.
• Casper Sleep Inc. CSPR dropped 9.6% to close at $9.99, declining further below its IPO issue price of $12 per share.
• Sol-Gel Technologies Ltd. SLGL fell 9.5% to close at $9.85.
• Rimini Street, Inc. RMNI dipped 9.4% to close at $4.33.
• Diamond Offshore Drilling, Inc. DO dropped 9.3% to close at $3.98 after the company reported Q4 earnings results.
• Schrodinger, Inc. SDGR fell 9.3% to close at $28.94. Schrodinger priced its IPO at $17 per share on Friday.
• PDS Biotechnology Corporation PDSB shares declined 8.8% to close at $2.08.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN dropped 8.2% to close at $47.06 after the company reported results from the Troriluzole study for generalized anxiety disorder missed the primary endpoint.